Clinical Trial Update: Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for a combination chemotherapy approach in relapsed or refractory Hodgkin lymphoma, spanning Phase 1 and Phase 2, with the trial now com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED